Brief: Gyre Therapeutics Reports Third Quarter 2024 And Year-To-Date Financial Results And Provides Business Update
13/11/2024 12:28
Nov 13 (Reuters) - Gyre Therapeutics Inc GYRE.O :
* GYRE THERAPEUTICS REPORTS THIRD QUARTER 2024 AND
YEAR-TO-DATE
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* GYRE THERAPEUTICS INC: QTRLY EPS $0.01
Source text: urn:newsml:reuters.com:*:nGNX6DL0cx
Further company coverage: GYRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes